GAINESVILLE, Fla. (February 22, 2021) – Digital health company, etectRx, Inc. recently announced Adam Standley as vice president of product management. In his new role, Standley’s main responsibility is setting the direction for the etectRx...
Read moreFailure Risk in Clinical Trials? An Easy-to-Swallow Solution
Our CEO Valerie Sullivan speaks in PharmaVOICE about failing clinical trials and our easy solution: the etectRx digital pill ID-Cap™ System. With our technology, there is no reason for clinical trial failure, and with growing remote...
Read moreDigital Pills and Clinical Trials – Pharma Blogger Gary Monk and etectRx CEO Valerie Sullivan
Pharmaceutical industry blogger Gary Monk talks with Valerie Sullivan, president and CEO of etectRx about how etectRx’s ID-Cap™ System can benefit pharmaceutical companies looking to increase effectiveness of clinical trials. Watch...
Read moreetectRx Announces Agreement to Advance Digital Sensors for Medication Adherence in Combination with Prescription Digital Therapeutics
GAINESVILLE, Fla. (January 14, 2021) – Digital health company, etectRx, Inc., announced today that it has entered into an agreement with Pear Therapeutics, Inc. to develop up to two product candidates in the Central Nervous System (CNS) space...
Read moreLong-Term Stability of the Electronic Sensor Component of a Digital Pill System in Real-World Storage Settings
Our ID-Cap System™ was recently utilized in a clinical study at Fenway Health in Boston, resulting in a research report drafted by Principal Investigator Dr. Peter Chai that surrounded the acceptance of digital pill data among study...
Read moreBetter Connections with Patients Using Data from Digital Pills
etectRx hosted an Xtalks Webinar on December 3: “Better Connections with Patients Using Data from Digital Pills.” Susan Baumgartner, VP of Product Management and Regulatory Affairs at etectRx, started the discussion speaking about medication...
Read moreDesign and Delivery of Real‑Time Adherence Data to Men Who Have Sex with Men Using Antiretroviral Pre‑exposure Prophylaxis via an Ingestible Electronic Sensor
Our ID-Cap System™ was recently utilized in a clinical study at Fenway Health in Boston, resulting in a paper drafted by Principal Investigator Dr. Peter Chai that surrounded the acceptance of digital pill data among study participants...
Read moreWebinar 12/3: Better Connections with Patients Using Data from Digital Pills
Digital pills offer the potential to help researchers truly understand connections between medication adherence and patient outcomes. The use of digital pills in clinical trials can help researchers have more confidence in their data, and can...
Read moreThe ID-Cap™ System: A Patient’s Perspective
“I felt confident that the digital pill was safe, I knew it was effective. I didn’t have to worry about whether I could remember taking it and truly, it changed the way I approached my own health” – Court, 31 You asked...
Read morePharma Pro Brings Experience to Digital Pill Company – Orlando Medical News
CEO Valerie Sullivan spoke with Orlando Medical News about how her pharma experience will benefit etectRx as it continues to innovate medication adherence. Full Story
Read moreetectRx Strengthens Intellectual Property Portfolio with 15th Issued Patent Supporting Digital Pill Innovation
GAINESVILLE, Fla. (October 7, 2020) – etectRx, Inc. recently announced that the United States Patent and Trademark Office has issued U.S. Patent 10,765,360 for an “Electronic medication compliance monitoring system and associated methods.” The...
Read moreetectRx™ Announces Clinical Study Aimed at Improving Medication Adherence
ID-Cap™ System Will Allow Clinicians to Remotely Track Ingestion Events and Provide Feedback to Patients GAINESVILLE, Fla. (September 10, 2020) – Digital health company etectRx™, Inc. (etectRx™), today announced that its...
Read more
